疫情浪潮与激增压力对既定COVID-19专用严重度评分预后判断的影响
该回顾性观察性队列研究纳入2020年3月1日至2022年1月31日美国281家医院298,379例住院COVID-19成人,评估m4C评分对院内死亡的判别与校准,并按医院-月计算激增指数。m4C在第一波AUC为0.779(95%CI 0.769-0.789),后续波次分别为0.772(95%CI 0.765-0.779)、0.746(95%CI 0.743-0.750)、delta波0.707(95%CI 0.702-0.712)、omicron波0.729(95%CI 0.721-0.738)。校准度在同期波次中下降且定期重校准后仍持续;校正激增指数与否性能相似。作者认为m4C对激增压力稳健,但近期波次性能退化,危机标准指南需频繁重新评估。
要点
- m4C评分对住院COVID-19患者院内死亡的判别力在第一波为AUC 0.779(95%CI 0.769-0.789),后续波次下降至delta波0.707(95%CI 0.702-0.712)。
- 校正医院激增指数前后m4C性能相似,提示其判别力对医疗激增压力稳健。
- m4C在同期波次中校准度下降,且定期重校准后仍持续存在。
- 作者认为,依赖固定预后评分(尤其用于COVID-19这类动态疾病)的危机标准指南需频繁重新评估以确保资源合理分配。
适用人群与场景
- 2020年3月1日至2022年1月31日美国281家医院住院的298,379例COVID-19成人患者。
诊断标准与关键阈值
- m4C评分由入院诊断代码、生命体征和实验室值计算。
- 医院激增指数为按严重度加权的COVID-19病例数,按医院-月计算。
研究设计与关键结果
- 研究类型为回顾性观察性队列研究,数据来自美国281家医院行政医疗数据集,纳入298,379例住院COVID-19成人。
- m4C对院内死亡的判别力:第一波AUC 0.779(95%CI 0.769-0.789);第二波0.772(95%CI 0.765-0.779);第三波0.746(95%CI 0.743-0.750);delta波0.707(95%CI 0.702-0.712);omicron波0.729(95%CI 0.721-0.738)。
- m4C在同期波次中校准度下降,且定期重校准后仍持续。
- 校正激增指数与否,m4C性能特征相似。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,m4C评分对激增压力稳健,使其在分诊最需要时具有吸引力;但评分在近期波次中性能退化。
- 作者认为,依赖固定预后评分的危机标准指南,尤其针对COVID-19这类动态疾病,需频繁重新评估以确保资源合理分配。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Many U.S. State crisis standards of care (CSC) guidelines incorporated Sequential Organ Failure Assessment (SOFA), a sepsis-related severity score, in pandemic triage algorithms. However, SOFA performed poorly in COVID-19. Although disease-specific scores may perform better, their prognostic utility over time and in overcrowded care settings remains unclear.
OBJECTIVES: We evaluated prognostication by the modified 4C (m4C) score, a COVID-19-specific prognosticator that demonstrated good predictive capacity early in the pandemic, as a potential tool to standardize triage across time and hospital-surge environments.
DESIGN: Retrospective observational cohort study.
SETTING: Two hundred eighty-one U.S. hospitals in an administrative healthcare dataset.
PARTICIPANTS: A total of 298,379 hospitalized adults with COVID-19 were identified from March 1, 2020, to January 31, 2022. m4C scores were calculated from admission diagnosis codes, vital signs, and laboratory values.
MAIN OUTCOMES AND MEASURES: Hospital-surge index, a severity-weighted measure of COVID-19 caseload, was calculated for each hospital-month. Discrimination of in-hospital mortality by m4C and surge index-adjusted models was measured by area under the receiver operating characteristic curves (AUC). Calibration was assessed by training models on early pandemic waves and measuring fit (deviation from bisector) in subsequent waves.
RESULTS: From March 2020 to January 2022, 298,379 adults with COVID-19 were admitted across 281 U.S. hospitals. m4C adequately discriminated mortality in wave 1 (AUC 0.779 [95% CI, 0.769-0.789]); discrimination was lower in subsequent waves (wave 2: 0.772 [95% CI, 0.765-0.779]; wave 3: 0.746 [95% CI, 0.743-0.750]; delta: 0.707 [95% CI, 0.702-0.712]; omicron: 0.729 [95% CI, 0.721-0.738]). m4C demonstrated reduced calibration in contemporaneous waves that persisted despite periodic recalibration. Performance characteristics were similar with and without adjustment for surge.
CONCLUSIONS AND RELEVANCE: Mortality prediction by the m4C score remained robust to surge strain, making it attractive for when triage is most needed. However, score performance has deteriorated in recent waves. CSC guidelines relying on defined prognosticators, especially for dynamic disease processes like COVID-19, warrant frequent reappraisal to ensure appropriate resource allocation.
参考来源
- Yek C, Wang J, Fintzi J, et al. Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19-Specific Severity Score. Crit Care Explor. 2023. PMID: 38094088. doi:10.1097/CCE.0000000000001021
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。